Vertex/CRISPR Nab First-Ever Gene Editing FDA Nod, Overshadow Bluebird’s Same-Day Win

 
• By Mandy Jackson
  
3d rendered medical illustration of a sickle cell
Both Casgevy and Lyfgenia are approved for patients aged 12 and up • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip